7 Papers
28 Citations
Linfeng Wu is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Drug carrier & Drug delivery. The author has an hindex of 5, co-authored 7 publications. Previous affiliations of Linfeng Wu include Thomas Jefferson University & Pennsylvania State University.
Chat about Author
Papers
Nanoparticles for drug delivery to the anterior segment of the eye.
TL;DR: The development of nanoparticles as drug carriers for improving the penetration and bioavailability of drugs to the anterior segment of the eye is summarized.
299
β-Cyclodextrin-poly(β-Amino Ester) Nanoparticles for Sustained Drug Delivery across the Blood–Brain Barrier
TL;DR: The developed β-cyclodextrin-poly(β-amino ester) nanoparticles might be useful as drug carriers for transporting drugs across the BBB to treat chronic diseases in the brain.
85
Long-acting injectable hormonal dosage forms for contraception.
TL;DR: The strategies exploited in the past to develop injectable hormonal contraceptive dosages including drug microcrystal suspensions, drug-loaded microsphere suspensions and in situ forming depot systems for long-term contraception are reviewed and the potential solutions for remaining issues met in the previous development are discussed.
46
Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic Rats.
Hisanori Imai,Gauri P. Misra,Linfeng Wu,Dileep R. Janagam,Thomas W. Gardner,Tao L. Lowe,Tao L. Lowe +6 more
TL;DR: The developed hydrogels have great potential to sustain release of insulin to the retina via subconjunctivally implantation to minimize DR without the risk of hypoglycemia.
30
Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
TL;DR: Different methods reported in the literature to circumvent the blood-brain barrier for enhancing the present of chemotherapeutics in the brain to treat pediatric brain tumors are reviewed.
23